Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An Economic Model to Establish the Costs Associated With Routes to Presentation for Patients With Multiple Myeloma in the United Kingdom.
Porteous A, Gibson S, Eddowes LA, Drayson M, Pratt G, Bowcock S, Willis F, Parkin H, Renwick S, Laketic-Ljubojevic I, Howell D, Smith A, Stern S. Porteous A, et al. Among authors: bowcock s. Value Health Reg Issues. 2023 May;35:27-33. doi: 10.1016/j.vhri.2023.01.001. Epub 2023 Feb 24. Value Health Reg Issues. 2023. PMID: 36841011 Free article.
Presenting Symptoms in Newly Diagnosed Myeloma, Relation to Organ Damage, and Implications for Symptom-Directed Screening: A Secondary Analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) Trial.
Bowcock S, Atkin C, Iqbal G, Pratt G, Yong K, Neal RD, Planche T, Karunanithi K, Jenkins S, Stern S, Arnott S, Toth P, Wandroo F, Dunn J, Drayson MT; TEAMM Trial Management Group and Trial Investigators. Bowcock S, et al. Cancers (Basel). 2023 Jun 25;15(13):3337. doi: 10.3390/cancers15133337. Cancers (Basel). 2023. PMID: 37444449 Free PMC article.
Longitudinal dynamics and clinically available predictors of poor response to COVID-19 vaccination in multiple myeloma.
Agarwal G, Moore S, Sadler R, Varghese S, Turner A, Chen LY, Larham J, Gray N, Carty O, Barrett J, Koshiaris C, Kothari J, Bowcock S, Oppermann U, Gamble V, Cook G, Kyriakou C, Drayson M, Basu S, McDonald S, McKinley S, Gooding S, Javaid MK, Ramasamy K. Agarwal G, et al. Among authors: bowcock s. Haematologica. 2024 Jun 1;109(6):1960-1965. doi: 10.3324/haematol.2023.284286. Haematologica. 2024. PMID: 38268439 Free PMC article. No abstract available.
Patient-reported symptoms and diagnostic journey in Multiple Myeloma.
Vijjhalwar R, Song K, Shrestha R, Bowcock S, Sanchez-Santos MT, Ramasamy K, Javaid MK. Vijjhalwar R, et al. Among authors: bowcock s. Front Oncol. 2023 Nov 30;13:1282569. doi: 10.3389/fonc.2023.1282569. eCollection 2023. Front Oncol. 2023. PMID: 38098501 Free PMC article.
Determinants of durable humoral and T cell immunity in myeloma patients following COVID-19 vaccination.
Twumasi C, Moore S, Sadler R, Jeans S, Varghese S, Turner A, Agarwal G, Larham J, Gray N, Carty O, Barrett J, Bowcock S, Oppermann U, Gamble V, Cook G, Kyriakou C, Drayson M, Basu S, McDonald S, McKinley S, Gooding S, Javaid MK, Ramasamy K. Twumasi C, et al. Among authors: bowcock s. Eur J Haematol. 2024 Apr;112(4):547-553. doi: 10.1111/ejh.14143. Epub 2023 Dec 20. Eur J Haematol. 2024. PMID: 38116695
Frailty-adjusted therapy in Transplant Non-Eligible patients with newly diagnosed Multiple Myeloma (FiTNEss (UK-MRA Myeloma XIV Trial)): a study protocol for a randomised phase III trial.
Coulson AB, Royle KL, Pawlyn C, Cairns DA, Hockaday A, Bird J, Bowcock S, Kaiser M, de Tute R, Rabin N, Boyd K, Jones J, Parrish C, Gardner H, Meads D, Dawkins B, Olivier C, Henderson R, Best P, Owen R, Jenner M, Kishore B, Drayson M, Jackson G, Cook G. Coulson AB, et al. Among authors: bowcock s. BMJ Open. 2022 Jun 2;12(6):e056147. doi: 10.1136/bmjopen-2021-056147. BMJ Open. 2022. PMID: 35654466 Free PMC article.
Immune response to COVID-19 vaccination is attenuated by poor disease control and antimyeloma therapy with vaccine driven divergent T-cell response.
Ramasamy K, Sadler R, Jeans S, Weeden P, Varghese S, Turner A, Larham J, Gray N, Carty O, Barrett J, Bowcock S, Oppermann U, Cook G, Kyriakou C, Drayson M, Basu S, Moore S, McDonald S, Gooding S, Javaid MK. Ramasamy K, et al. Among authors: bowcock s. Br J Haematol. 2022 May;197(3):293-301. doi: 10.1111/bjh.18066. Epub 2022 Feb 17. Br J Haematol. 2022. PMID: 35064676 Free PMC article.
COVID symptoms, testing, shielding impact on patient-reported outcomes and early vaccine responses in individuals with multiple myeloma.
Ramasamy K, Sadler R, Jeans S, Varghese S, Turner A, Larham J, Gray N, Barrett J, Bowcock S, Cook G, Kyriakou C, Smith D, Drayson M, Basu S, Moore S, McDonald S, Gooding S, Javaid MK. Ramasamy K, et al. Among authors: bowcock s. Br J Haematol. 2022 Jan;196(1):95-98. doi: 10.1111/bjh.17764. Epub 2021 Aug 2. Br J Haematol. 2022. PMID: 34341984 Free PMC article. No abstract available.
81 results